当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析 - 现金流量表

联环药业

(600513)

  

流通市值:56.09亿  总市值:56.09亿
流通股本:2.85亿   总股本:2.85亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金699,388,521.492,904,021,687.312,037,034,996.331,276,964,705.54
  收到的税费返还178,595.169,063,835.2--
  收到其他与经营活动有关的现金9,154,591.7528,603,895.744,110,866.320,038,191.49
  经营活动现金流入小计708,721,708.42,941,689,418.212,081,145,862.631,297,002,897.03
  购买商品、接受劳务支付的现金464,967,131.011,826,172,932.891,263,182,059.53748,693,152.21
  支付给职工以及为职工支付的现金77,849,478.75239,244,868.51170,132,783.72107,949,942.51
  支付的各项税费40,066,293.86131,755,891.6158,533,205.81114,683,028.59
  支付其他与经营活动有关的现金204,793,306.16758,985,808.82662,178,968.82483,486,386.72
  经营活动现金流出小计787,676,209.782,956,159,501.822,254,027,017.881,454,812,510.03
  经营活动产生的现金流量净额-78,954,501.38-14,470,083.61-172,881,155.25-157,809,613
二、投资活动产生的现金流量:
  收回投资收到的现金-5,610,000--
  取得投资收益收到的现金-5,549.58--
  处置固定资产、无形资产和其他长期资产收回的现金净额-79,873.9216,4686,468
  投资活动现金流入的平衡项目-000
  投资活动现金流入小计-5,695,423.516,4686,468
  购建固定资产、无形资产和其他长期资产支付的现金59,913,763.79271,396,270.6167,767,322.53132,788,855.17
  投资支付的现金-18,060,000125,009,52873,495,298.11
  取得子公司及其他营业单位支付的现金-202,240,164.77--
  投资活动现金流出小计59,913,763.79491,696,435.37292,776,850.53206,284,153.28
  投资活动产生的现金流量净额-59,913,763.79-486,001,011.87-292,760,382.53-206,277,685.28
三、筹资活动产生的现金流量:
  取得借款收到的现金349,109,337.161,539,762,062.841,223,929,218.01971,181,555.46
  收到其他与筹资活动有关的现金25,000,00055,000,00082,489,00015,000,000
  筹资活动现金流入小计374,109,337.161,594,762,062.841,306,418,218.01986,181,555.46
  偿还债务支付的现金290,037,500887,811,597.85651,569,847.75466,456,514.42
  分配股利、利润或偿付利息支付的现金15,005,619.3152,332,422.2845,126,236.0236,205,754.02
  其中:子公司支付给少数股东的股利、利润-5,365,000-5,365,000
  支付其他与筹资活动有关的现金15,000,00062,149,316.2179,828,022.7258,167,639.01
  筹资活动现金流出小计320,043,119.311,002,293,336.34776,524,106.49560,829,907.45
  筹资活动产生的现金流量净额54,066,217.85592,468,726.5529,894,111.52425,351,648.01
四、汇率变动对现金及现金等价物的影响-269,396.66-340,194.21160,194.55221,602.02
五、现金及现金等价物净增加额-85,071,443.9891,657,436.8164,412,768.2961,485,951.75
  加:期初现金及现金等价物余额278,351,322.05186,693,885.24186,693,885.24186,693,885.24
  期末现金及现金等价物余额193,279,878.07278,351,322.05251,106,653.53248,179,836.99
补充资料:
  净利润--84,152,794.56--32,357,597.04
  资产减值准备-10,860,329.06-927,206.48
  固定资产和投资性房地产折旧-77,570,122.78-31,302,262.03
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-77,570,122.78-31,302,262.03
  无形资产摊销-19,467,387.07-10,096,922.66
  长期待摊费用摊销-1,501,684.53-934,054.43
  处置固定资产、无形资产和其他长期资产的损失-77,537.02--5,723.89
  固定资产报废损失-993,430.69-21,815.28
  财务费用-32,630,390.25-15,270,367.37
  投资损失-8,898,993.87-1,491,479.24
  递延所得税--18,067,075.56-717,074.63
  其中:递延所得税资产减少--6,959,754.97-1,076,819.49
    递延所得税负债增加--11,107,320.59--359,744.86
  存货的减少--54,175,590.68--20,343,726.1
  经营性应收项目的减少--24,446,711.81--164,636,393.33
  经营性应付项目的增加-6,374,325.19--4,514,868.96
  现金的期末余额-278,351,322.05-248,179,836.99
  减:现金的期初余额-186,693,885.24-186,693,885.24
  现金及现金等价物的净增加额-91,657,436.81-61,485,951.75
公告日期2026-04-282026-04-212025-10-252025-08-27
审计意见(境内)标准无保留意见
TOP↑